We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.48B
AUM Growth
+$121M
Cap. Flow
+$68.3M
Cap. Flow %
1.96%
Top 10 Hldgs %
12.54%
Holding
1,594
New
179
Increased
532
Reduced
584
Closed
199

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$8.12M
2
KMI icon
Kinder Morgan
KMI
+$7.34M
3
ILMN icon
Illumina
ILMN
+$6.91M
4
DD icon
DuPont de Nemours
DD
+$6.77M
5
NVGS icon
Navigator Holdings
NVGS
+$6.1M

Sector Composition

Rank Sector Weight
1 Healthcare 12.04%
2 Industrials 10.15%
3 Energy 9.83%
4 Financials 9.31%
5 Technology 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEGR
601
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.01M 0.03%
48,150
+31,250
+185% +$787K
FXR icon
602
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$728M
$1M 0.03%
33,008
+11,710
+55% +$347K
RF icon
603
Regions Financial
RF
$26.4B
$994K 0.03%
94,151
-4,485
-5% -$44.8K
BLV icon
604
Vanguard Long-Term Bond ETF
BLV
$5.71B
$990K 0.03%
10,501
-100
-0.9% -$9.23K
CP icon
605
Canadian Pacific Kansas City
CP
$78.1B
$990K 0.03%
25,690
-375
-1% -$14.8K
HIG icon
606
Hartford Financial Services
HIG
$38.9B
$987K 0.03%
23,680
+2,100
+10% +$83.1K
EXPE icon
607
Expedia Group
EXPE
$35.4B
$984K 0.03%
11,529
+608
+6% +$51.6K
WYNN icon
608
Wynn Resorts
WYNN
$10.3B
$983K 0.03%
6,610
-33
-0.5% -$5.67K
PGF icon
609
Invesco Financial Preferred ETF
PGF
$677M
$980K 0.03%
53,684
-17,470
-25% -$317K
CXO
610
DELISTED
CONCHO RESOURCES INC.
CXO
$976K 0.03%
+9,781
New +$1.03M
PCTY icon
611
Paylocity
PCTY
$7.38B
$975K 0.03%
37,330
+3,010
+9% +$75.6K
BRKL
612
DELISTED
Brookline Bancorp
BRKL
$974K 0.03%
97,042
+1,301
+1% +$12.3K
SJNK icon
613
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
$972K 0.03%
33,608
+6,830
+26% +$201K
RPV icon
614
Invesco S&P 500 Pure Value ETF
RPV
$1.65B
$969K 0.03%
17,634
-3,174
-15% -$170K
DF
615
DELISTED
Dean Foods Company
DF
$968K 0.03%
+49,925
New +$794K
SNDK
616
DELISTED
SANDISK CORP
SNDK
$965K 0.03%
9,849
-32,177
-77% -$3.08M
ALXN
617
DELISTED
Alexion Pharmaceuticals
ALXN
$964K 0.03%
5,208
-1,943
-27% -$360K
AET
618
DELISTED
Aetna Inc
AET
$964K 0.03%
10,858
+2,383
+28% +$200K
EEFT icon
619
Euronet Worldwide
EEFT
$2.72B
$955K 0.03%
17,408
-2,600
-13% -$139K
EW icon
620
Edwards Lifesciences
EW
$49.6B
$953K 0.03%
44,856
+13,722
+44% +$276K
GXP
621
DELISTED
Great Plains Energy Incorporated
GXP
$951K 0.03%
33,471
-38
-0.1% -$1K
OGCP
622
Empire State Realty Series 60
OGCP
$1.47B
$950K 0.03%
53,685
SPN
623
DELISTED
Superior Energy Services, Inc.
SPN
$950K 0.03%
4,713
+1,503
+47% +$352K
ADSK icon
624
Autodesk
ADSK
$49.5B
$940K 0.03%
15,650
+80
+0.5% +$4.63K
MGC icon
625
Vanguard Morningstar Mega Cap ETF
MGC
$9.99B
$937K 0.03%
13,338
-28
-0.2% -$1.93K

Similar funds

Oppenheimer & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Oppenheimer & Co held 1,594 positions worth $3.48B, up 3.6% from $3.36B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q4 2014 filing shows 179 new, 532 increased, 584 reduced and 199 closed positions. Its largest new stake was First American: 99,605 shares worth $3.38M. The largest sale was IBM, an estimated $5.56M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Industrials and Energy.

  • Oppenheimer & Co's largest Q4 2014 buy was First American: 99,605 shares worth $3.38M.
  • Oppenheimer & Co added most to Alibaba in Q4 2014, an estimated $8.12M increase.
  • Oppenheimer & Co's biggest Q4 2014 reduction was IBM, cutting an estimated $5.56M.
  • Oppenheimer & Co fully exited Tesla in Q4 2014, selling an estimated $4.59M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.48B portfolio in Q4 2014.
  • Oppenheimer & Co opened 179 new positions and closed 199 in Q4 2014.
  • Oppenheimer & Co's portfolio value rose 3.6% quarter-over-quarter to $3.48B.

Based on Oppenheimer & Co's 13F filing for Q4 2014, filed 10 Feb 2015.